Leslie S. Johnson

Person

Darnestown, MD, US

People

Patents Grantslast 30 patents

Information Patent Grant
Bispecific binding molecules that are capable of binding CD137 and...
- Patent number 11,942,149
- Issue date Mar 26, 2024
- MacroGenics, Inc.
- Liqin Liu
- G11 - INFORMATION STORAGE
Information Patent Grant
Compound targeting IL-23A and B-cell activating factor (BAFF) and u...
- Patent number 11,884,744
- Issue date Jan 30, 2024
- Boehringer Ingelheim International GmbH
- Sanjaya Singh
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
LAG-3-binding molecules and methods of use thereof
- Patent number 11,858,991
- Issue date Jan 2, 2024
- MacroGenics, Inc.
- Ross La Motte-Mohs
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of using bispecific molecules having immunoreactivity with...
- Patent number 11,840,571
- Issue date Dec 12, 2023
- MacroGenics, Inc.
- Leslie S. Johnson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multi-chain polypeptide-containing tri-specific binding molecules
- Patent number 11,820,818
- Issue date Nov 21, 2023
- MacroGenics, Inc.
- Leslie S. Johnson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific CD16-binding molecules and their use in the treatment of...
- Patent number 11,795,226
- Issue date Oct 24, 2023
- MacroGenics, Inc.
- Gundo Diedrich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tri-specific binding molecules that specifically bind to multiple c...
- Patent number 11,697,684
- Issue date Jul 11, 2023
- MacroGenics, Inc.
- Ezio Bonvini
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Variant CD3-binding domains and their use in combination therapies...
- Patent number 11,685,781
- Issue date Jun 27, 2023
- Ezio Bonvini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compound targeting IL-23A and TNF-alpha and uses thereof
- Patent number 11,680,096
- Issue date Jun 20, 2023
- Boehringer Ingelheim International GmbH
- Rachel Rebecca Barrett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Bi-specific monovalent diabodies that are capable of binding CD19 a...
- Patent number 11,639,386
- Issue date May 2, 2023
- MacroGenics, Inc.
- Leslie S. Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PD-1-binding molecules and methods of use thereof
- Patent number 11,623,959
- Issue date Apr 11, 2023
- MacroGenics, Inc.
- Kalpana Shah
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
B7-H3 directed antibody drug conjugates
- Patent number 11,591,400
- Issue date Feb 28, 2023
- MacroGenics, Inc.
- Deryk T. Loo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific binding molecules that are capable of binding CD137 and...
- Patent number 11,459,394
- Issue date Oct 4, 2022
- MacroGenics, Inc.
- Liqin Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific molecules that are immunoreactive with immune effector c...
- Patent number 11,421,031
- Issue date Aug 23, 2022
- MacroGenics, Inc.
- Scott Koenig
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Bi-specific monovalent Fc diabodies that are capable of binding CD3...
- Patent number 11,384,149
- Issue date Jul 12, 2022
- MacroGenics, Inc.
- Leslie S. Johnson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Covalent diabodies and uses thereof
- Patent number 11,254,748
- Issue date Feb 22, 2022
- MacroGenics, Inc.
- Leslie S. Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Covalent diabodies and uses thereof
- Patent number 11,254,747
- Issue date Feb 22, 2022
- MacroGenics, Inc.
- Leslie S. Johnson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
ADAM9-binding molecules, and methods of use thereof
- Patent number 11,242,402
- Issue date Feb 8, 2022
- MacroGenics, Inc.
- Deryk T. Loo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD3-binding molecules capable of binding to human and non-human CD3
- Patent number 11,111,299
- Issue date Sep 7, 2021
- MacroGenics, Inc.
- Ling Huang
- H01 - BASIC ELECTRIC ELEMENTS
Information Patent Grant
Covalently bonded diabodies having immunoreactivity with PD-1 and L...
- Patent number 11,098,119
- Issue date Aug 24, 2021
- MacroGenics, Inc.
- Ezio Bonvini
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
FcγRIIB-specific antibodies and methods of use thereof
- Patent number 11,098,125
- Issue date Aug 24, 2021
- MacroGenics, Inc.
- Leslie S. Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
LAG-3-binding molecules and methods of use thereof
- Patent number 11,072,653
- Issue date Jul 27, 2021
- MacroGenics, Inc.
- Ross La Motte-Mohs
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
HER2/neu-specific antibodies and methods of using same
- Patent number 11,028,183
- Issue date Jun 8, 2021
- MacroGenics, Inc.
- Leslie S. Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
B7-H3 binding molecules, antibody drug conjugates thereof and metho...
- Patent number 10,961,311
- Issue date Mar 30, 2021
- MacroGenics, Inc.
- Deryk T. Loo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific molecules having immunoreactivity with PD-1 and CTLA-4,...
- Patent number 10,954,301
- Issue date Mar 23, 2021
- MacroGenics, Inc.
- Leslie S. Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bi-specific monovalent diabodies that are capable of binding to gpA...
- Patent number 10,858,430
- Issue date Dec 8, 2020
- MacroGenics, Inc.
- Paul A. Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compound targeting IL-23A and B-cell activating factor (BAFF) and u...
- Patent number 10,844,138
- Issue date Nov 24, 2020
- Boehringer Ingelheim International GmbH
- Sanjaya Singh
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compound targeting IL-23A and TNF-alpha and uses thereof
- Patent number 10,793,629
- Issue date Oct 6, 2020
- Boehringer Ingelheim International GmbH
- Rachel Rebecca Barrett
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Bi-specific monovalent diabodies that are capable of binding CD123...
- Patent number 10,787,521
- Issue date Sep 29, 2020
- MacroGenics, Inc.
- Ezio Bonvini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bispecific molecules that are immunoreactive with immune effector c...
- Patent number 10,730,947
- Issue date Aug 4, 2020
- MacroGenics, Inc.
- Scott Koenig
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
LAG-3-Binding Molecules and Methods of Use Thereof
- Publication number 20240124582
- Publication date Apr 18, 2024
- MacroGenics, Inc.
- Ross La Motte-Mohs
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE C...
- Publication number 20240117036
- Publication date Apr 11, 2024
- MacroGenics, Inc.
- Ezio BONVINI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF USING BISPECIFIC MOLECULES HAVING IMMUNOREACTIVITY WITH...
- Publication number 20240084015
- Publication date Mar 14, 2024
- MacroGenics, Inc.
- Leslie S. Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Variant CD3-Binding Domains and Their Use in Combination Therapies...
- Publication number 20240043537
- Publication date Feb 8, 2024
- MacroGenics, Inc.
- Ezio Bonvini
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bi-Specific Monovalent Diabodies That are Capable of Binding CD19 a...
- Publication number 20230399399
- Publication date Dec 14, 2023
- MacroGenics, Inc.
- Leslie S. Johnson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUND TARGETING IL-23A AND TNF-ALPHA AND USES THEREOF
- Publication number 20230382988
- Publication date Nov 30, 2023
- Boehringer Ingelheim International GmbH
- Rachel Rebecca Barrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Covalent Diabodies and Uses Thereof
- Publication number 20230382996
- Publication date Nov 30, 2023
- MacroGenics, Inc.
- Leslie S. Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PD-1-BINDING MOLECULES AND METHODS OF USE THEREOF
- Publication number 20230357404
- Publication date Nov 9, 2023
- MacroGenics, Inc.
- Kalpana Shah
- C07 - ORGANIC CHEMISTRY
Information Patent Application
B7-H3 DIRECTED ANTIBODY DRUG CONJUGATES
- Publication number 20230272084
- Publication date Aug 31, 2023
- MacroGenics, Inc.
- Deryk T. LOO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific Molecules That Are Immunoreactive With Immune Effector C...
- Publication number 20230167178
- Publication date Jun 1, 2023
- MacroGenics, Inc.
- Scott Koenig
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BISPECIFIC BINDING MOLECULES THAT ARE CAPABLE OF BINDING CD137 AND...
- Publication number 20220406376
- Publication date Dec 22, 2022
- MacroGenics, Inc.
- Liqin LIU
- G11 - INFORMATION STORAGE
Information Patent Application
Bi-Specific Monovalent Fc Diabodies That Are Capable of Binding CD3...
- Publication number 20220372144
- Publication date Nov 24, 2022
- MacroGenics, Inc.
- Leslie S. Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADAM9-Binding Molecules, and Methods of Use Thereof
- Publication number 20220324995
- Publication date Oct 13, 2022
- MacroGenics, Inc.
- Deryk T. Loo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Covalent Diabodies and Uses Thereof
- Publication number 20220275082
- Publication date Sep 1, 2022
- MacroGenics, Inc.
- Leslie S. Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FcgammaRIIB-Specific Antibodies and Methods of Use Thereof
- Publication number 20220177574
- Publication date Jun 9, 2022
- MacroGenics, Inc.
- Leslie S. Johnson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HER2/neu-Specific Antibodies and Methods of Using Same
- Publication number 20220089773
- Publication date Mar 24, 2022
- MacroGenics, Inc.
- Leslie S. Johnson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD3-Binding Molecules Capable of Binding to Human and Non-Human CD3
- Publication number 20220056131
- Publication date Feb 24, 2022
- MacroGenics, Inc.
- Ling Huang
- C03 - GLASS MINERAL OR SLAG WOOL
Information Patent Application
Covalently Bonded Diabodies Having Immunoreactivity with PD-1 and L...
- Publication number 20220041714
- Publication date Feb 10, 2022
- MacroGenics, Inc.
- Ezio Bonvini
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOCONJUGATES TARGETING ADAM9 AND METHODS OF USE THEREOF
- Publication number 20210388102
- Publication date Dec 16, 2021
- ImmunoGen, Inc.
- Stuart William Hicks
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOCONJUGATES TARGETING ADAM9 AND METHODS OF USE THEREOF
- Publication number 20210275685
- Publication date Sep 9, 2021
- ImmunoGen, Inc.
- Stuart William Hicks
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Optimized gp41-Binding Molecules and Uses Thereof
- Publication number 20210246194
- Publication date Aug 12, 2021
- MacroGenics, Inc.
- Chia-Ying Kao Lam
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LAG-3-Binding Molecules and Methods of Use Thereof
- Publication number 20210206851
- Publication date Jul 8, 2021
- MacroGenics, Inc.
- Ross La Motte-Mohs
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific CD16-Binding Molecules and Their Use in the Treatment of...
- Publication number 20210171630
- Publication date Jun 10, 2021
- MacroGenics, Inc.
- Gundo Diedrich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL B7-H3 BINDING MOLECULES, ANTIBODY DRUG CONJUGATES THEREOF AND...
- Publication number 20210171641
- Publication date Jun 10, 2021
- MacroGenics, Inc.
- Deryk T. LOO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Variant CD3-Binding Domains and Their Use in Combination Therapies...
- Publication number 20210155694
- Publication date May 27, 2021
- MacroGenics, Inc.
- Ezio Bonvini
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF USING BISPECIFIC MOLECULES HAVING IMMUNOREACTIVITY WITH...
- Publication number 20210130470
- Publication date May 6, 2021
- MacroGenics, Inc.
- Leslie S. Johnson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUND TARGETING IL-23A AND B-CELL ACTIVATING FACTOR (BAFF) AND U...
- Publication number 20210107998
- Publication date Apr 15, 2021
- Boehringer Ingelheim International GmbH
- SANJAYA SINGH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bispecific Molecules That Are Immunoreactive With Immune Effector C...
- Publication number 20210095021
- Publication date Apr 1, 2021
- MacroGenics, Inc.
- Scott Koenig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUND TARGETING IL-23A AND TNF-ALPHA AND USES THEREOF
- Publication number 20210054065
- Publication date Feb 25, 2021
- Boehringer Ingelheim International GmbH
- Rachel Rebecca Barrett
- G01 - MEASURING TESTING
Information Patent Application
Bi-Specific Monovalent Diabodies That are Capable of Binding CD123...
- Publication number 20210047426
- Publication date Feb 18, 2021
- MacroGenics, Inc.
- Ezio Bonvini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Leslie S. Johnson

Person

Patents Grantslast 30 patents

Bispecific binding molecules that are capable of binding CD137 and...

Compound targeting IL-23A and B-cell activating factor (BAFF) and u...

LAG-3-binding molecules and methods of use thereof

Methods of using bispecific molecules having immunoreactivity with...

Multi-chain polypeptide-containing tri-specific binding molecules

Bispecific CD16-binding molecules and their use in the treatment of...

Tri-specific binding molecules that specifically bind to multiple c...

Variant CD3-binding domains and their use in combination therapies...

Compound targeting IL-23A and TNF-alpha and uses thereof

Bi-specific monovalent diabodies that are capable of binding CD19 a...

PD-1-binding molecules and methods of use thereof

B7-H3 directed antibody drug conjugates

Bispecific binding molecules that are capable of binding CD137 and...

Bispecific molecules that are immunoreactive with immune effector c...

Bi-specific monovalent Fc diabodies that are capable of binding CD3...

Covalent diabodies and uses thereof

Covalent diabodies and uses thereof

ADAM9-binding molecules, and methods of use thereof

CD3-binding molecules capable of binding to human and non-human CD3

Covalently bonded diabodies having immunoreactivity with PD-1 and L...

FcγRIIB-specific antibodies and methods of use thereof

LAG-3-binding molecules and methods of use thereof

HER2/neu-specific antibodies and methods of using same

B7-H3 binding molecules, antibody drug conjugates thereof and metho...

Bispecific molecules having immunoreactivity with PD-1 and CTLA-4,...

Bi-specific monovalent diabodies that are capable of binding to gpA...

Compound targeting IL-23A and B-cell activating factor (BAFF) and u...

Compound targeting IL-23A and TNF-alpha and uses thereof

Bi-specific monovalent diabodies that are capable of binding CD123...

Bispecific molecules that are immunoreactive with immune effector c...

Patents Applicationslast 30 patents

LAG-3-Binding Molecules and Methods of Use Thereof

TRI-SPECIFIC BINDING MOLECULES THAT SPECIFICALLY BIND TO MULTIPLE C...

METHODS OF USING BISPECIFIC MOLECULES HAVING IMMUNOREACTIVITY WITH...

Variant CD3-Binding Domains and Their Use in Combination Therapies...

Bi-Specific Monovalent Diabodies That are Capable of Binding CD19 a...

COMPOUND TARGETING IL-23A AND TNF-ALPHA AND USES THEREOF

Covalent Diabodies and Uses Thereof

PD-1-BINDING MOLECULES AND METHODS OF USE THEREOF

B7-H3 DIRECTED ANTIBODY DRUG CONJUGATES

Bispecific Molecules That Are Immunoreactive With Immune Effector C...

BISPECIFIC BINDING MOLECULES THAT ARE CAPABLE OF BINDING CD137 AND...

Bi-Specific Monovalent Fc Diabodies That Are Capable of Binding CD3...

ADAM9-Binding Molecules, and Methods of Use Thereof

Covalent Diabodies and Uses Thereof

FcgammaRIIB-Specific Antibodies and Methods of Use Thereof

HER2/neu-Specific Antibodies and Methods of Using Same

CD3-Binding Molecules Capable of Binding to Human and Non-Human CD3

Covalently Bonded Diabodies Having Immunoreactivity with PD-1 and L...

IMMUNOCONJUGATES TARGETING ADAM9 AND METHODS OF USE THEREOF

IMMUNOCONJUGATES TARGETING ADAM9 AND METHODS OF USE THEREOF

Optimized gp41-Binding Molecules and Uses Thereof

LAG-3-Binding Molecules and Methods of Use Thereof

Bispecific CD16-Binding Molecules and Their Use in the Treatment of...

NOVEL B7-H3 BINDING MOLECULES, ANTIBODY DRUG CONJUGATES THEREOF AND...

Variant CD3-Binding Domains and Their Use in Combination Therapies...

METHODS OF USING BISPECIFIC MOLECULES HAVING IMMUNOREACTIVITY WITH...

COMPOUND TARGETING IL-23A AND B-CELL ACTIVATING FACTOR (BAFF) AND U...

Bispecific Molecules That Are Immunoreactive With Immune Effector C...

COMPOUND TARGETING IL-23A AND TNF-ALPHA AND USES THEREOF

Bi-Specific Monovalent Diabodies That are Capable of Binding CD123...